Absci Corporation share price logo

Absci Corporation Share Price

NASDAQ: ABSI

Small Cap

$2.94

-0.02

(-0.68%)

as on

Absci Corporation Stock Performance

as on March 24, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.85
    $3.02
    downward going graph

    3.06%

    Downside

    2.72%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.01
    $5.23
    downward going graph

    31.63%

    Downside

    77.82%

    Upside

    downward going graph

Absci Corporation share price movements today

Previous Close
$2.96
Open
$3.02
Volume
4.0M
Day's Low - High
$2.85 - $3.02
52 Week Low - High
$2.01 - $5.23

Absci Corporation Historical Returns

1 Month Return
+ 11.7 %
3 Month Return
-15.91 %
1 Year Return
-1.66 %
3 Year Return
+ 72.09 %
5 Year Return
0 %

Absci Corporation Stock Fundamentals & Key Indicators

Check Absci Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$445.1M

EPS (TTM)

-0.798

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.29

Industry PE ratio

-4.738881355932204

PEG Ratio

0

EBITDA

-105.5M

Revenue (TTM)

2.8M

Profit Margin

0.00%

Return On Equity TTM

-55.68%

Absci Corporation Stock Valuation

Track how Absci Corporation P/E has moved over time to understand its valuation trends.

Absci Corporation in the last 5 years

  • Overview

  • Trends

Lowest (-5.61x)

December 31, 2025

Today (-5.29x)

March 23, 2026

Industry (-4.74x)

March 23, 2026

Highest (-1.32x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: -5.29x

Absci Corporation vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Absci Corporation with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Absci Corporation image
Absci Corporation
BUY$445.1MNA-5.290.00%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$41.4B125.13%133.418.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.3B112.56%29.6732.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.6BNA1115.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$77.5B56.01%17.6731.41%

Stock Returns calculator for Absci Corporation Stock including INR - Dollar returns

The Absci Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Absci Corporation investment value today

Current value as on today

₹1,07,594

Returns

₹7,594

(+7.59%)

Returns from Absci Corporation Stock

₹2,326 (-2.33%)

Dollar Returns*

₹9,919 (+9.92%)

Analyst Recommendation on Absci Corporation Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Absci Corporation. Average target price of $8.05

Absci Corporation Share Price Target

Get share price movements and forecasts by analysts on Absci Corporation.

What analysts predicted

63.48%UPSIDE

Target Price

$8.05

Current Price

$2.94

Analyzed by

12 Analysts

Target

$8.05

Absci Corporation target price $8.05, a slight upside of 63.48% compared to current price of $2.94. According to 12 analysts rating.

Absci Corporation Stock’s Investor Sentiment and Interest

Search interest for Absci Corporation Stock has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:10% versus previous 30 day period

Absci Corporation Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
3
0
0
0
1
1
0
1
0
0
Gross Profit
-8
-10
-11
-11
-13
-1
-16
-15
-19
0
Operating Income
-42
-23
-24
-23
-26
-28
-29
-27
-31
-30
EBITDA
-18
-19
-20
-20
-23
-23
-25
-24
-28
-25
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
3
3
3
3
3
3
3
3
3
2
Income Before Tax
-41
-21
-23
-21
-24
-27
-28
-26
-30
-28
Income Tax Expense
0
0
0
0
24
0
0
0
0
0
Net Income
-41
-21
-23
-21
-24
-27
-28
-26
-30
-28
Net Profit Margin
-1237.66%
-2956.18%
-6965.98%
-2447.10%
-1948.82%
-1610.70%
-4358.35%
-2234.61%
-5154.97%
-7594.18%

Absci Corporation Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
2
4
4
5
5
4
Gross Profit
2
-6
-39
-53
-41
-57
Operating Income
-6
-13
-75
-106
-115
-108
EBITDA
-5
-12
-67
-93
-79
-94
Interest Expense
0
0
3
0
1
0
Depreciation
0
1
6
13
14
13
Income Before Tax
-6
-14
-109
-105
-110
-103
Income Tax Expense
0
0
-8
0
0
0
Net Income
-6
-14
-100
-104
-110
-103
Net Profit Margin
-319.61%
-300.27%
-2111.25%
-1825.37%
-1933.65%
-2274.06%

Absci Corporation Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-21
-23
-21
-24
-27
-28
-26
-30
-28
Operating Cash Flow
-10
-14
-17
-16
-20
-16
-21
-16
-25
Investing Cash Flow
20
18
-76
1
14
19
-15
9
-63
Financing Cash Flow
0
-1
81
0
0
0
42
-1
60
Change in Cash
8
2
-13
-15
-5
3
5
-8
-28

Absci Corporation Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-14
-100
-104
-110
-103
Operating Cash Flow
-10
-60
-81
-64
-72
Investing Cash Flow
-2
-67
-126
81
-41
Financing Cash Flow
70
336
5
-4
82
Change in Cash
57
208
-203
12
-31

Global Institutional Holdings in Absci Corporation

Funds
Holdings
Geode Capital Management, LLC
2.15%
Bank of America Corp
1.25%
Two Sigma Investments LLC
0.94%
FMR Inc
14.88%
Woodline Partners LP
1.52%
See all

Absci Corporation News & Key Events

  • img

    Today's Timeline - 11 September

    Thu, 09:30 PM

    -

    Absci collaborates with Oracle and AMD to enhance its generative AI Drug Creation Platform, accelerating drug discovery processes.

Insights on Absci Corporation

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -30.56M → -28.70M (in $), with an average increase of 6.5% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, ABSI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ABSI stock has moved up by 18.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 11.3% return, outperforming this stock by 13.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 1.17M → 378.0K (in $), with an average decrease of 43.0% per quarter

About Absci Corporation

Absci Corporation is a clinical-stage biopharmaceutical company advancing therapeutics with generative design. Its Integrated Drug Creation platform combines artificial intelligence (AI) models with a synthetic biology data engine, enabling the design of therapeutics that address challenging therapeutic targets. Its approach leverages a continuous feedback loop between advanced AI algorithms and wet lab validation. Alongside collaborations with pharmaceutical, biotech, tech, and academic companies, the Company is advancing its own pipeline of AI- designed therapeutics. These include ABS-101, an antibody to treat inflammatory bowel disease (IBD), as well as other indications, and ABS-201, for hair regrowth with the potential to redefine treatment possibilities for androgenetic alopecia, commonly known as male and female pattern baldness. It has four wholly owned, internally developed programs focusing on cytokine biology. Its other pipeline programs include ABS-301 and ABS-501.
OrganisationAbsci Corporation
Headquarters18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683
IndustryServices
CEOMr. Sean McClain
E-voting on sharesClick here to vote

Key Management of Absci Corporation

Name

Title

Dr. Zachariah Jonasson Ph.D.

Chief Business Officer & CFO

Mr. Todd Bedrick CPA

Senior VP & Chief Accounting Officer

Mr. Alexander Khan CPA

CVP of Finance & Head of Investor Relations

Mr. Wen Sha

Chief of Staff

Dr. Christine Lemke D.V.M., M.B.A., Ph.D.

Senior Vice President of Portfolio & Growth Strategy

Mr. Sean McClain

Founder, CEO, President & Director

Ms. Karin Wierinck

Chief People Officer

Melissa Patterson Ph.D.

Chief of Staff

Anders Kassow

Head of Intellectual Property

Ms. Shelby Walker J.D.

Chief Legal Officer

FAQs

What is Absci Corporation share price today?

Absci Corporation share price today is $2.94 as on at the close of the market. Absci Corporation share today touched a day high of $3.02 and a low of $2.85.

What is the 52 week high and 52 week low for Absci Corporation share?

Absci Corporation share touched a 52 week high of $5.23 on and a 52 week low of $2.01 on . Absci Corporation stock price today i.e. is closed at $2.94,which is 43.76% down from its 52 week high and 46.27% up from its 52 week low.

What is Absci Corporation's market capitalisation today?

Absci Corporation market capitalisation is $0.00T as on .

How to invest in Absci Corporation Stock (ABSI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Absci Corporation on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Absci Corporation Shares that will get you 0.5102 shares as per Absci Corporation share price of $2.94 per share as on March 24, 2026 at 1:29 am IST.

What is the minimum amount required to buy Absci Corporation Stock (ABSI) from India?

Indian investors can start investing in Absci Corporation (ABSI) shares with as little as ₹94.058 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹940.58 in Absci Corporation stock (as per the Rupee-Dollar exchange rate as on ). Based on Absci Corporation share’s latest price of $2.94 as on March 24, 2026 at 1:29 am IST, you will get 3.4014 shares of Absci Corporation. Learn more about fractional shares .